ArticleFrontiers in oncology2023

Clinical efficacy and safety evaluation of camrelizumab plus lenvatinib in adjuvant therapy after hepatocellular carcinoma surgery.

Xudan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.